BRIEF published on 11/10/2025 at 18:00, 24 days 12 hours ago Galenica Successfully Places CHF 250 Million Bond Long-term Financing SIX Swiss Exchange Bond Placement Galenica AG CHF 250 Million
PRESS RELEASE published on 11/10/2025 at 17:55, 24 days 12 hours ago Galenica successfully places a bond of over CHF 250 million Galenica successfully places a CHF 250 million bond, reducing short-term liabilities and securing long-term financing. Proceeds used for Labor Team Group acquisition and general corporate purposes Acquisition Financing Bond Swiss Exchange Galenica
BRIEF published on 10/23/2025 at 06:45, 1 month 12 days ago Galenica AG to continue its sustained growth in 2025 Growth Galenica Pharmacy Drugs Labor Team
PRESS RELEASE published on 10/23/2025 at 06:40, 1 month 12 days ago Galenica remains on growth track Galenica Group reports 4.7% sales growth in Q3 2025 driven by prescription drugs and dietary supplements. Acquisition of Labor Team boosts expectations for sales and EBIT1 growth Sales Growth Dietary Supplements Galenica Prescription Drugs Labor Team
BRIEF published on 10/21/2025 at 08:00, 1 month 14 days ago Galenica Unveils Innovative Pharmacy Concept to Meet Evolving Needs Customer Experience Healthcare Digital Integration Galenica AG Pharmacy Concept
PRESS RELEASE published on 10/21/2025 at 07:55, 1 month 14 days ago Galenica strengthens basic care with new pharmacy concept Galenica tests new pharmacy concept focusing on consultations and customer experience at Amavita pharmacy in Zurich's Glattzentrum. Launch aims to reshape future pharmacies Customer Experience Galenica Pharmacy Concept Consultations Amavita
BRIEF published on 09/10/2025 at 06:50, 2 months 24 days ago Galenica Enters Diagnostics with Labor Team Acquisition Acquisition Diagnostics Galenica AG Healthcare Network Labor Team
PRESS RELEASE published on 09/10/2025 at 06:45, 2 months 24 days ago Launch of Galenica Diagnostics: Acquisition of Labor Team completed Galenica completes acquisition of Labor Team, forming Galenica Diagnostics. Fourth-largest Swiss lab to operate under Galenica. Board members merge Galenica and lab expertise Acquisition Switzerland Galenica Diagnostics Labor Team
BRIEF published on 08/07/2025 at 06:50, 3 months 28 days ago Galenica AG: Half-year growth and upward revision of EBIT forecasts Adjusted EBIT Prescription Drugs Galenica Growth Health Products And Services Swiss Pharmaceutical Market
PRESS RELEASE published on 08/07/2025 at 06:45, 3 months 28 days ago Galenica demonstrates pleasing growth and improves EBIT guidance Galenica AG demonstrates pleasing growth with 5.0% increase in Group sales, raising EBIT guidance by 7%-9%. Adjusted EBIT grows by 10.9% in the first half of 2025 Growth EBIT Guidance Galenica AG Group Sales First Half 2025
Published on 12/05/2025 at 02:35, 3 hours 41 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 16 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 11 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 16 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 46 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 25 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 51 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 1 minute ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 5 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 16 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 31 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 32 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 15 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
